nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ABCB1—Methylprednisolone—ankylosing spondylitis	0.162	0.167	CbGbCtD
Indacaterol—ABCB1—Betamethasone—ankylosing spondylitis	0.105	0.108	CbGbCtD
Indacaterol—ABCB1—Prednisolone—ankylosing spondylitis	0.104	0.107	CbGbCtD
Indacaterol—ABCB1—Prednisone—ankylosing spondylitis	0.098	0.101	CbGbCtD
Indacaterol—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.097	0.0999	CbGbCtD
Indacaterol—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0735	0.0757	CbGbCtD
Indacaterol—CYP3A4—Betamethasone—ankylosing spondylitis	0.063	0.065	CbGbCtD
Indacaterol—CYP3A4—Prednisolone—ankylosing spondylitis	0.0622	0.0641	CbGbCtD
Indacaterol—ABCB1—Dexamethasone—ankylosing spondylitis	0.0612	0.0631	CbGbCtD
Indacaterol—CYP3A4—Prednisone—ankylosing spondylitis	0.0587	0.0605	CbGbCtD
Indacaterol—ABCB1—Methotrexate—ankylosing spondylitis	0.0492	0.0507	CbGbCtD
Indacaterol—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0367	0.0378	CbGbCtD
Indacaterol—Chronic obstructive pulmonary disease—Methotrexate—ankylosing spondylitis	0.00139	0.0468	CcSEcCtD
Indacaterol—Oropharyngeal pain—Triamcinolone—ankylosing spondylitis	0.000661	0.0223	CcSEcCtD
Indacaterol—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.000545	0.0184	CcSEcCtD
Indacaterol—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.000501	0.0169	CcSEcCtD
Indacaterol—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.0005	0.0169	CcSEcCtD
Indacaterol—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.000455	0.0153	CcSEcCtD
Indacaterol—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.000455	0.0153	CcSEcCtD
Indacaterol—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.000396	0.0134	CcSEcCtD
Indacaterol—Asthma—Triamcinolone—ankylosing spondylitis	0.000377	0.0127	CcSEcCtD
Indacaterol—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00037	0.0125	CcSEcCtD
Indacaterol—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00036	0.0121	CcSEcCtD
Indacaterol—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00036	0.0121	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00035	0.0118	CcSEcCtD
Indacaterol—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000335	0.0113	CcSEcCtD
Indacaterol—Infestation—Methylprednisolone—ankylosing spondylitis	0.000335	0.0113	CcSEcCtD
Indacaterol—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.000331	0.0112	CcSEcCtD
Indacaterol—Hypokalaemia—Prednisone—ankylosing spondylitis	0.000314	0.0106	CcSEcCtD
Indacaterol—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000309	0.0104	CcSEcCtD
Indacaterol—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000309	0.0104	CcSEcCtD
Indacaterol—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000296	0.00997	CcSEcCtD
Indacaterol—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000279	0.00941	CcSEcCtD
Indacaterol—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000272	0.00916	CcSEcCtD
Indacaterol—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000271	0.00914	CcSEcCtD
Indacaterol—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000269	0.00905	CcSEcCtD
Indacaterol—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000262	0.00883	CcSEcCtD
Indacaterol—Vertigo—Prednisolone—ankylosing spondylitis	0.000257	0.00865	CcSEcCtD
Indacaterol—Asthma—Methotrexate—ankylosing spondylitis	0.000249	0.00839	CcSEcCtD
Indacaterol—Vertigo—Triamcinolone—ankylosing spondylitis	0.000236	0.00795	CcSEcCtD
Indacaterol—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000235	0.00793	CcSEcCtD
Indacaterol—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000234	0.00789	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000231	0.0078	CcSEcCtD
Indacaterol—Cough—Triamcinolone—ankylosing spondylitis	0.000229	0.00772	CcSEcCtD
Indacaterol—Tachycardia—Prednisolone—ankylosing spondylitis	0.000227	0.00767	CcSEcCtD
Indacaterol—Myalgia—Triamcinolone—ankylosing spondylitis	0.000224	0.00753	CcSEcCtD
Indacaterol—Pneumonia—Methotrexate—ankylosing spondylitis	0.000223	0.00752	CcSEcCtD
Indacaterol—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000223	0.00752	CcSEcCtD
Indacaterol—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000222	0.00748	CcSEcCtD
Indacaterol—Infestation—Methotrexate—ankylosing spondylitis	0.000222	0.00748	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000222	0.00747	CcSEcCtD
Indacaterol—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000219	0.00737	CcSEcCtD
Indacaterol—Immune system disorder—Prednisone—ankylosing spondylitis	0.000215	0.00726	CcSEcCtD
Indacaterol—Vertigo—Dexamethasone—ankylosing spondylitis	0.000214	0.00721	CcSEcCtD
Indacaterol—Vertigo—Betamethasone—ankylosing spondylitis	0.000214	0.00721	CcSEcCtD
Indacaterol—Infection—Triamcinolone—ankylosing spondylitis	0.000213	0.00718	CcSEcCtD
Indacaterol—Infection—Methylprednisolone—ankylosing spondylitis	0.000212	0.00716	CcSEcCtD
Indacaterol—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00021	0.00707	CcSEcCtD
Indacaterol—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000209	0.00705	CcSEcCtD
Indacaterol—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000209	0.00705	CcSEcCtD
Indacaterol—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000209	0.00703	CcSEcCtD
Indacaterol—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000208	0.007	CcSEcCtD
Indacaterol—Malnutrition—Prednisone—ankylosing spondylitis	0.000208	0.00699	CcSEcCtD
Indacaterol—Myalgia—Dexamethasone—ankylosing spondylitis	0.000203	0.00684	CcSEcCtD
Indacaterol—Myalgia—Betamethasone—ankylosing spondylitis	0.000203	0.00684	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000195	0.00658	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000195	0.00657	CcSEcCtD
Indacaterol—Infection—Betamethasone—ankylosing spondylitis	0.000193	0.00651	CcSEcCtD
Indacaterol—Infection—Dexamethasone—ankylosing spondylitis	0.000193	0.00651	CcSEcCtD
Indacaterol—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000192	0.00649	CcSEcCtD
Indacaterol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000192	0.00647	CcSEcCtD
Indacaterol—Anaemia—Prednisone—ankylosing spondylitis	0.000192	0.00646	CcSEcCtD
Indacaterol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000191	0.00644	CcSEcCtD
Indacaterol—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000191	0.00643	CcSEcCtD
Indacaterol—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000191	0.00643	CcSEcCtD
Indacaterol—Tachycardia—Betamethasone—ankylosing spondylitis	0.00019	0.0064	CcSEcCtD
Indacaterol—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00019	0.0064	CcSEcCtD
Indacaterol—Vertigo—Prednisone—ankylosing spondylitis	0.000186	0.00628	CcSEcCtD
Indacaterol—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000185	0.00623	CcSEcCtD
Indacaterol—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00018	0.00606	CcSEcCtD
Indacaterol—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00018	0.00605	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000177	0.00597	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000177	0.00597	CcSEcCtD
Indacaterol—Myalgia—Prednisone—ankylosing spondylitis	0.000177	0.00595	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000175	0.00591	CcSEcCtD
Indacaterol—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000175	0.00588	CcSEcCtD
Indacaterol—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000175	0.00588	CcSEcCtD
Indacaterol—Malnutrition—Methotrexate—ankylosing spondylitis	0.000173	0.00584	CcSEcCtD
Indacaterol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000172	0.00579	CcSEcCtD
Indacaterol—Infection—Prednisone—ankylosing spondylitis	0.000168	0.00567	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000168	0.00566	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000168	0.00566	CcSEcCtD
Indacaterol—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000166	0.0056	CcSEcCtD
Indacaterol—Tachycardia—Prednisone—ankylosing spondylitis	0.000165	0.00557	CcSEcCtD
Indacaterol—Skin disorder—Prednisone—ankylosing spondylitis	0.000165	0.00554	CcSEcCtD
Indacaterol—Anaemia—Methotrexate—ankylosing spondylitis	0.00016	0.0054	CcSEcCtD
Indacaterol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000158	0.00532	CcSEcCtD
Indacaterol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000158	0.00531	CcSEcCtD
Indacaterol—Vertigo—Methotrexate—ankylosing spondylitis	0.000156	0.00525	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000154	0.0052	CcSEcCtD
Indacaterol—Dizziness—Prednisolone—ankylosing spondylitis	0.000154	0.00519	CcSEcCtD
Indacaterol—Paraesthesia—Prednisone—ankylosing spondylitis	0.000152	0.00512	CcSEcCtD
Indacaterol—Pruritus—Triamcinolone—ankylosing spondylitis	0.000152	0.00511	CcSEcCtD
Indacaterol—Cough—Methotrexate—ankylosing spondylitis	0.000151	0.0051	CcSEcCtD
Indacaterol—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000151	0.0051	CcSEcCtD
Indacaterol—Myalgia—Methotrexate—ankylosing spondylitis	0.000148	0.00498	CcSEcCtD
Indacaterol—Chest pain—Methotrexate—ankylosing spondylitis	0.000148	0.00498	CcSEcCtD
Indacaterol—Rash—Prednisolone—ankylosing spondylitis	0.000147	0.00495	CcSEcCtD
Indacaterol—Dermatitis—Prednisolone—ankylosing spondylitis	0.000147	0.00495	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000147	0.00494	CcSEcCtD
Indacaterol—Headache—Prednisolone—ankylosing spondylitis	0.000146	0.00492	CcSEcCtD
Indacaterol—Dizziness—Triamcinolone—ankylosing spondylitis	0.000142	0.00478	CcSEcCtD
Indacaterol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000141	0.00477	CcSEcCtD
Indacaterol—Infection—Methotrexate—ankylosing spondylitis	0.000141	0.00474	CcSEcCtD
Indacaterol—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000139	0.00468	CcSEcCtD
Indacaterol—Nausea—Prednisolone—ankylosing spondylitis	0.000138	0.00467	CcSEcCtD
Indacaterol—Pruritus—Betamethasone—ankylosing spondylitis	0.000138	0.00464	CcSEcCtD
Indacaterol—Pruritus—Dexamethasone—ankylosing spondylitis	0.000138	0.00464	CcSEcCtD
Indacaterol—Skin disorder—Methotrexate—ankylosing spondylitis	0.000137	0.00463	CcSEcCtD
Indacaterol—Rash—Triamcinolone—ankylosing spondylitis	0.000135	0.00455	CcSEcCtD
Indacaterol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000135	0.00455	CcSEcCtD
Indacaterol—Rash—Methylprednisolone—ankylosing spondylitis	0.000135	0.00454	CcSEcCtD
Indacaterol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000135	0.00454	CcSEcCtD
Indacaterol—Headache—Triamcinolone—ankylosing spondylitis	0.000134	0.00452	CcSEcCtD
Indacaterol—Headache—Methylprednisolone—ankylosing spondylitis	0.000134	0.00451	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000129	0.00435	CcSEcCtD
Indacaterol—Dizziness—Betamethasone—ankylosing spondylitis	0.000129	0.00433	CcSEcCtD
Indacaterol—Dizziness—Dexamethasone—ankylosing spondylitis	0.000129	0.00433	CcSEcCtD
Indacaterol—Nausea—Triamcinolone—ankylosing spondylitis	0.000127	0.00429	CcSEcCtD
Indacaterol—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000127	0.00428	CcSEcCtD
Indacaterol—Nausea—Methylprednisolone—ankylosing spondylitis	0.000127	0.00428	CcSEcCtD
Indacaterol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000126	0.00425	CcSEcCtD
Indacaterol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000125	0.0042	CcSEcCtD
Indacaterol—Rash—Dexamethasone—ankylosing spondylitis	0.000123	0.00413	CcSEcCtD
Indacaterol—Rash—Betamethasone—ankylosing spondylitis	0.000123	0.00413	CcSEcCtD
Indacaterol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000123	0.00413	CcSEcCtD
Indacaterol—Dermatitis—Betamethasone—ankylosing spondylitis	0.000123	0.00413	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000122	0.00412	CcSEcCtD
Indacaterol—Headache—Betamethasone—ankylosing spondylitis	0.000122	0.00411	CcSEcCtD
Indacaterol—Headache—Dexamethasone—ankylosing spondylitis	0.000122	0.00411	CcSEcCtD
Indacaterol—Pruritus—Prednisone—ankylosing spondylitis	0.00012	0.00404	CcSEcCtD
Indacaterol—Nausea—Dexamethasone—ankylosing spondylitis	0.000116	0.00389	CcSEcCtD
Indacaterol—Nausea—Betamethasone—ankylosing spondylitis	0.000116	0.00389	CcSEcCtD
Indacaterol—Dizziness—Prednisone—ankylosing spondylitis	0.000112	0.00377	CcSEcCtD
Indacaterol—Rash—Prednisone—ankylosing spondylitis	0.000107	0.0036	CcSEcCtD
Indacaterol—Dermatitis—Prednisone—ankylosing spondylitis	0.000107	0.0036	CcSEcCtD
Indacaterol—Headache—Prednisone—ankylosing spondylitis	0.000106	0.00358	CcSEcCtD
Indacaterol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000104	0.00351	CcSEcCtD
Indacaterol—Nausea—Prednisone—ankylosing spondylitis	0.000101	0.00339	CcSEcCtD
Indacaterol—Pruritus—Methotrexate—ankylosing spondylitis	0.0001	0.00337	CcSEcCtD
Indacaterol—Dizziness—Methotrexate—ankylosing spondylitis	9.36e-05	0.00315	CcSEcCtD
Indacaterol—Rash—Methotrexate—ankylosing spondylitis	8.92e-05	0.00301	CcSEcCtD
Indacaterol—Dermatitis—Methotrexate—ankylosing spondylitis	8.92e-05	0.003	CcSEcCtD
Indacaterol—Headache—Methotrexate—ankylosing spondylitis	8.87e-05	0.00299	CcSEcCtD
Indacaterol—Nausea—Methotrexate—ankylosing spondylitis	8.41e-05	0.00283	CcSEcCtD
